Eton Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eton Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Eton Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $210K, a 40.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $210K +$61K +40.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $74K -$95K -56.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $92K -$96K -51.1% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $109K +$67K +160% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $149K +$86K +137% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $169K +$85K +101% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $188K +$84K +80.8% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $42K -$81K -65.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $63K -$80K -55.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $84K $0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $104K -$88K -45.8% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $123K +$60K +95.2% Sep 30, 2021 10-Q 2021-11-16
Q2 2021 $143K +$47K +49% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $84K -$45K -34.9% Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $192K +$32K +20% Dec 31, 2020 10-K 2022-03-16
Q3 2020 $63K -$128K -67% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $96K -$126K -56.8% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $129K -$123K -48.8% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $160K -$121K -43.1% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $191K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $222K Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $252K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $281K Jan 2, 2019 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.